2025 Calendar Targeted Therapy. P53, encoded by tp53, the commonest mutated gene in cancer, is an appealing target for systemic anticancer therapies including those designed to restore p53 function. Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread.
Attendees will have the chance to learn from clinicians, researchers, and regulators, and benefit cancer patients worldwide. Thank you to those who joined us for #ttlc24!
Plan Your Participation In The Esmo Targeted Anticancer Therapies Congress 2025, Taking Place From 3 To 5 March 2025 In Paris, France.
Tolerance & resistance to targeted therapy in nsclc.
Attendees Will Have The Chance To Learn From Clinicians, Researchers, And Regulators, And Benefit Cancer Patients Worldwide.
Generated by openai for boothsquare.
The Study Drug, Tng462, Is A Selective Prmt5 Inhibitor Administered Orally.
Images References :
2024 Is The 50Th Anniversary Of The International Association For The Study Of Lung Cancer, And As We Enter This Monumental Year For Iaslc, We Do So Under A New Strategic Plan.
To discuss what the future of iaslc looks like, hosts dr.
Esmo Tat, Known As 'The Home Of Phase I In Oncology' Offers Participants A Glimpse Of The Future Of Targeted Anticancer Therapies, Focusing On Promising New Anticancer Targets And Agents, With A Particular Focus On Those In Early Phase Clinical Development.
Generated by openai for boothsquare.
Narjust Florez Interview Four Iaslc Leaders To Provide A Glimpse Into Where The Association.